Literature DB >> 8443491

Gangliosides and neurological diseases.

M Alter.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8443491      PMCID: PMC1676571          DOI: 10.1136/bmj.306.6871.204

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

1.  Bovine gangliosides and acute motor polyneuropathy.

Authors:  A Figueras; F J Morales-Olivas; D Capellà; V Palop; J R Laporte
Journal:  BMJ       Date:  1992-11-28

2.  Validity of cerebral arterial blood flow calculations from velocity measurements.

Authors:  H A Kontos
Journal:  Stroke       Date:  1989-01       Impact factor: 7.914

3.  Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.

Authors:  F H Geisler; F C Dorsey; W P Coleman
Journal:  N Engl J Med       Date:  1991-06-27       Impact factor: 91.245

4.  Monosialoganglioside in subarachnoid hemorrhage.

Authors:  I Papo; A Benedetti; A Carteri; G A Merli; S Mingrino; R Bruno
Journal:  Stroke       Date:  1991-01       Impact factor: 7.914

  4 in total
  2 in total

1.  The Therapeutic Role of Gangliosides in Neurological Disorders.

Authors:  J S Schneider
Journal:  CNS Drugs       Date:  1994-03       Impact factor: 5.749

2.  Gangliosides and Guillain-Barré syndrome. Science supports the use of gangliosides.

Authors:  M Massarotti; R Matano
Journal:  BMJ       Date:  1994-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.